Trial · NCT04524273

Adverse events168

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 168

Type	Event	Organ system	Group	Affected	At risk
other	Diarrhoea	Gastrointestinal disorders	RCP: Placebo	8	119
other	Diarrhoea	Gastrointestinal disorders	RCP: Inebilizumab 300 mg	4	119
other	Diarrhoea	Gastrointestinal disorders	Optional OLP: Inebilizumab 300 mg	1	178
other	COVID-19	Infections and infestations	RCP: Placebo	9	119
other	COVID-19	Infections and infestations	RCP: Inebilizumab 300 mg	12	119
other	COVID-19	Infections and infestations	Optional OLP: Inebilizumab 300 mg	10	178
other	Nasopharyngitis	Infections and infestations	RCP: Placebo	3	119
other	Nasopharyngitis	Infections and infestations	RCP: Inebilizumab 300 mg	8	119
other	Nasopharyngitis	Infections and infestations	Optional OLP: Inebilizumab 300 mg	8	178
other	Upper respiratory tract infection	Infections and infestations	RCP: Placebo	7	119
other	Upper respiratory tract infection	Infections and infestations	RCP: Inebilizumab 300 mg	4	119
other	Upper respiratory tract infection	Infections and infestations	Optional OLP: Inebilizumab 300 mg	11	178
other	Urinary tract infection	Infections and infestations	RCP: Placebo	3	119
other	Urinary tract infection	Infections and infestations	RCP: Inebilizumab 300 mg	8	119
other	Urinary tract infection	Infections and infestations	Optional OLP: Inebilizumab 300 mg	2	178
other	Infusion related reaction	Injury, poisoning and procedural complications	RCP: Placebo	3	119
other	Infusion related reaction	Injury, poisoning and procedural complications	RCP: Inebilizumab 300 mg	7	119
other	Infusion related reaction	Injury, poisoning and procedural complications	Optional OLP: Inebilizumab 300 mg	2	178
other	Arthralgia	Musculoskeletal and connective tissue disorders	RCP: Placebo	8	119
other	Arthralgia	Musculoskeletal and connective tissue disorders	RCP: Inebilizumab 300 mg	5	119

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04524273/events

API reference For AI assistants

Adverse events168

Sources 3

Read this list from software.